R&D
Partner Content
2nd Molecular Glue Drug Development Summit 2024
Molecular glue development continues to gain exponential momentum, …
19804 items found
Sales & Marketing
How to evaluate an omnichannel solution: A simple framework
In today’s complex communications landscape, the path of information …
Oncology
Sponsored
Understanding and addressing care disparities in rare cancers
Any cancer diagnosis is scary and signals a long, challenging road …
R&D
Partner Content
mRNA Assay Development Summit 2023
The mRNA Assay Development Summit is the first and only meeting to …
Patients
Partner Content
The Multilayered Impact of Rare Disease on Relationships
Life with a rare condition can have a significant impact – and often …
Patients
Understanding patient flow forecasting
Patient flow forecasting is a fundamental tool in healthcare and …
News
FDA advisors unconvinced by BrainStorm’s ALS cell therapy
An FDA advisory committee has voted by a huge margin that …
Patients
The NHS risk crisis: The failure of risk in a complex healthcare system
*Disclaimer: The views and opinions expressed here are the author’s …
Oncology
Sponsored
Planting seeds of success: A new early-stage fund in Cancer Tech
Debiopharm Innovation Fund, the Swiss biopharma’s strategic investing …
News
BridgeBio’s $250m raise heads latest biotech financings
BridgeBio Pharma has raised $250 million from the sale of nine …
Digital
News
Costco builds in telehealth with $29 online visit
US retailer Costco has made a play for a bigger slice of the …
R&D
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal...
Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Sales & Marketing
Sponsored
Seeking a single source of truth: Standardisation of the dat...
Oskar Mӧbert, Vice President of OpenData at Veeva Systems, spoke with Ian Cornish, Associate Director of Data Platforms at Astellas, about the company’s decision to opt into Veeva’s OpenDat
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
